MI
IBIO icon

Motiv8 Investments’s iBio IBIO Stock Holding History

Motiv8 Investments’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 950

Other funds holding IBIO

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Motiv8 Investments's IBIO Position: Q4 2025 in Review

Motiv8 Investments opened a new position in iBio (IBIO) in Q4 2025: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #950 among its holdings.

50 funds tracked by Wall St. Rank hold IBIO as of Q4 2025.

  • Motiv8 Investments held 1 share of iBio worth $0 as of Q4 2025.
  • iBio was a new Motiv8 Investments position in Q4 2025.
  • iBio made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #950 holding.
  • 50 funds tracked by Wall St. Rank held iBio as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.